BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

SEGALL BRYANT & HAMILL, LLC's Holding History (CIK: 0001006378)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 1,134,813 Value ($000) $8,613 Avg Close $8.33 Range $7.42 - $9.23
Q2 2025
Shares 1,220,077 Value ($000) $10,932 Avg Close $9.31 Range $6.02 - $11.31
Q1 2025
Shares 1,330,314 Value ($000) $9,977 Avg Close $8.07 Range $6.96 - $9.50
Q4 2024
Shares 1,422,196 Value ($000) $10,695 Avg Close $7.59 Range $6.85 - $8.44
Q3 2024
Shares 1,490,376 Value ($000) $11,327 Avg Close $7.60 Range $6.17 - $8.88
Q2 2024
Shares 1,526,481 Value ($000) $9,434 Avg Close $5.52 Range $4.03 - $6.99
Q1 2024
Shares 1,749,448 Value ($000) $8,887 Avg Close $5.62 Range $4.82 - $7.75
Q4 2023
Shares 1,739,317 Value ($000) $10,419 Avg Close $5.79 Range $4.83 - $7.06
Q3 2023
Shares 2,017,986 Value ($000) $14,287 Avg Close $7.18 Range $6.62 - $7.95
Q2 2023
Shares 2,037,688 Value ($000) $14,345 Avg Close $8.02 Range $6.87 - $9.07
Q1 2023
Shares 1,837,854 Value ($000) $15 Avg Close $9.63 Range $7.82 - $12.08
Q4 2022
Shares 1,668,999 Value ($000) $19 Avg Close $12.47 Range $10.36 - $14.50
Q2 2022
Shares 1,823,209 Value ($000) $19,292 Avg Close $10.32 Range $7.61 - $18.00
Q1 2022
Shares 943,792 Value ($000) $15,346 Avg Close $16.04 Range $11.56 - $19.99